Equine Protozoal Myeloencephalitis, commonly known as EPM, is a serious neurological disease that affects horses throughout North America. Caused by the parasite Sarcocystis neurona, EPM damages the spinal cord and brain, leading to progressive weakness, incoordination, and loss of muscular control. The disease is endemic in many regions of the United States, with horses at higher risk in areas where opossums—the primary host for the parasite—are prevalent. Understanding the symptoms, diagnosis, and treatment options is critical for horse owners who want to recognize the disease early and provide their animals with the best chance for recovery.
This article provides an overview of EPM’s clinical presentation, diagnostic procedures, and treatment approaches based on current veterinary knowledge. However, this information is educational and not a substitute for professional veterinary diagnosis or treatment. If you suspect your horse may have EPM or notice signs of neurological disease, contact an equine veterinarian immediately. Early diagnosis and prompt treatment significantly improve outcomes.
What is EPM?
Equine Protozoal Myeloencephalitis is an infectious disease triggered by the protozoan parasite Sarcocystis neurona. Horses become infected by ingesting feed, water, or hay contaminated with oocysts shed by infected opossums. Once in the horse’s digestive system, the parasite crosses the intestinal barrier and migrates to the central nervous system, where it causes inflammation and damage to the spinal cord and brain tissue.
The disease affects horses of all ages, though it most commonly appears in young to middle-aged animals. Stress, immunosuppression, and concurrent illness may increase a horse’s susceptibility to developing clinical signs after exposure to the parasite. Many horses are exposed to Sarcocystis neurona without developing symptomatic disease, suggesting that infection alone does not guarantee illness—host factors play a significant role in disease progression.
Clinical Symptoms of EPM
EPM symptoms vary widely depending on the location and extent of parasite-induced inflammation in the central nervous system. Symptoms may develop acutely over days to weeks or progress insidiously over months. Common clinical signs include:
- Incoordination (ataxia) and loss of balance, often beginning in the hind limbs
- Muscle weakness and fatigue, particularly after exercise
- Asymmetrical gait abnormalities (dragging one hind leg more than the other)
- Spasticity or stiffness in the limbs
- Difficulty backing up or turning sharply
- Stumbling, tripping, or crossing limbs while walking
- Facial drooping or loss of facial nerve function
- Difficulty swallowing (dysphagia)
- Behavior changes or altered mental status
- Muscle atrophy in hindquarters or shoulders
- Seizures in severe cases
Symptoms often appear worse when the horse is tired, moving on challenging terrain, or turning in tight circles. Some horses show improvement during rest periods, only to worsen with exercise, creating a confusing pattern for owners. Progressive deterioration without treatment is typical, though the rate of decline varies among individual horses.
When to Call Your Veterinarian
Contact your equine veterinarian immediately if your horse exhibits sudden onset of incoordination, unexplained weakness, facial drooping, difficulty swallowing, or behavioral changes. These symptoms warrant urgent evaluation to rule out EPM and other serious neurological conditions. Do not delay—early intervention significantly impacts treatment outcomes.
Diagnosis of EPM
Diagnosing EPM requires a combination of clinical examination, laboratory testing, and imaging studies. Your veterinarian will begin with a thorough neurological examination to assess gait, reflexes, cranial nerve function, and proprioception. This examination helps localize the lesion within the nervous system.
Diagnostic Tests
Cerebrospinal Fluid (CSF) Analysis: A spinal tap collects cerebrospinal fluid from the subarachnoid space, which is examined for elevated protein levels, pleocytosis (increased cell count), and specific antibodies against Sarcocystis neurona. This test is the most specific for EPM diagnosis, though not all infected horses show positive results.
Serology: Blood tests detect antibodies against the parasite using Western blot or ELISA techniques. However, serology cannot distinguish between infected horses that developed clinical disease and those with subclinical infection or prior exposure. A positive serum test combined with clinical signs and supportive CSF findings strengthens the diagnosis.
Magnetic Resonance Imaging (MRI): MRI reveals inflammation, edema, or demyelination in the spinal cord and brain. This imaging modality provides valuable information about lesion location and severity, helping to confirm EPM and exclude other neurological diseases such as cervical vertebral stenosis or trauma.
Myelography or CT Imaging: In some cases, myelography or computed tomography may be recommended to evaluate spinal cord compression or other structural abnormalities.
Treatment Options for EPM
Several antiprotozoal medications are used to treat EPM, each with different efficacy rates and side effect profiles. Treatment success depends on early diagnosis, prompt initiation of therapy, the extent of central nervous system damage, and individual patient factors. Recovery typically requires 4 to 12 weeks of consistent treatment, with some horses requiring extended therapy or maintenance treatment.
First-Line Medications
Ponazuril: Ponazuril is an antiprotozoal agent administered as a paste or liquid by mouth, typically at 7.5 mg/kg once daily for 28 days. Studies show clinical improvement in 60 to 80 percent of treated horses. The medication concentrates well in the central nervous system and has an excellent safety profile. Mild gastrointestinal upset is the most common side effect.
Diclazuril: Diclazuril is given at 10 mg/kg daily for 28 days. This medication has demonstrated efficacy comparable to ponazuril in clinical trials, with improvement rates of 50 to 75 percent. It is well tolerated and may be administered as a powder mixed with feed or as a paste.
Alternative and Adjunctive Treatments
Toltrazuril: This antiprotozoal medication is administered at 10 mg/kg daily. Some practitioners use toltrazuril as a second-line agent or in combination with other treatments when initial response is inadequate.
Supportive Care: Alongside antiprotozoal therapy, supportive measures improve outcomes and comfort. These include:
- Stall rest during acute disease phases to prevent falls and secondary injuries
- Careful footing to reduce slipping and stumbling in affected horses
- Physical therapy and controlled hand-walking as the horse improves
- Nutritional support and high-quality hay to maintain body condition
- Management of concurrent infections or illness
- Monitoring for complications such as secondary infections or laminitis
Prognosis and Recovery
The prognosis for EPM varies widely. Approximately 60 to 80 percent of treated horses show clinical improvement, though not all achieve complete recovery. Factors that influence prognosis include the duration of clinical signs before treatment begins, the severity of neurological deficits, the location of lesions in the central nervous system, and the individual horse’s immune response.
Horses treated within days of symptom onset generally show better recovery than those with chronic infection lasting months. Some horses achieve complete resolution of clinical signs and return to full athletic function, while others experience residual incoordination or weakness even after treatment. A small percentage of horses show little to no improvement despite appropriate therapy.
Recurrence of clinical signs is possible in some horses after treatment completion, particularly if the immune system does not establish effective parasite control. Your veterinarian may recommend extended or repeated treatment protocols if relapse occurs.
Prevention of EPM
While no vaccine currently prevents EPM in horses, several management practices reduce infection risk:
- Eliminate or reduce opossum access to barns, feed storage areas, and water sources through secure fencing and removal of food attractants
- Store hay and grain in sealed, opossum-proof containers
- Use covered feeders and water troughs to prevent contamination with opossum feces
- Remove fallen fruit, pet food, and other attractants from the property
- Maintain clean pasture management to reduce feed spoilage and contamination
- Consider geographic location and local EPM prevalence when evaluating risk for your operation
Frequently Asked Questions
Can EPM be transmitted from horse to horse?
No, EPM cannot be transmitted directly between horses. Horses become infected only through exposure to oocysts shed by infected opossums or, rarely, through consumption of infected intermediate hosts such as birds or rodents. Direct contact between affected and healthy horses poses no EPM transmission risk.
How long does EPM treatment typically last?
Standard EPM treatment protocols range from 28 to 56 days, depending on the medication used and individual response. Ponazuril and diclazuril are typically given for 28 days. Your veterinarian may recommend extended treatment if clinical signs persist after the initial protocol, or may prescribe maintenance therapy to prevent recurrence.
Is EPM fatal?
EPM is not inherently fatal, and many horses survive and recover with appropriate treatment. However, severe neurological disease may leave a horse unsafe to ride or unable to function normally. In rare cases of acute, fulminant infection or severe immunosuppression, the disease may progress to death. Early diagnosis and prompt treatment significantly improve survival and functional outcomes.
What is the cost of EPM treatment?
EPM treatment costs vary depending on diagnostic procedures, medication choice, duration of therapy, and regional veterinary fees. Diagnostic workup including examination, serology, and CSF analysis may cost $1,500 to $3,000. Medication costs for 28 days of ponazuril or diclazuril typically range from $300 to $800. Total treatment costs, including multiple veterinary visits and supportive care, often exceed $3,000 to $5,000 for a complete course of therapy.
Key Takeaways
- EPM is a serious neurological disease caused by the parasite Sarcocystis neurona, transmitted through contamination by infected opossums.
- Early symptoms include incoordination, weakness, and asymmetrical gait abnormalities; contact your veterinarian immediately if you observe these signs.
- Diagnosis requires neurological examination, cerebrospinal fluid analysis, serology, and often MRI imaging to confirm disease and exclude other conditions.
- Antiprotozoal medications such as ponazuril and diclazuril improve clinical signs in 60 to 80 percent of treated horses when initiated early.
- Prognosis depends on disease duration before treatment, severity of neurological deficits, and individual immune response; many treated horses achieve functional recovery.
- Prevention focuses on eliminating opossum access to feed, water, and barn areas through secure storage and property management.
- This article provides educational information only and is not a substitute for professional veterinary diagnosis or treatment.
Leave a Reply